The FTO gene polymorphism (rs9939609) is associated with metabolic syndrome in morbidly obese subjects from southern Italy

Molecular and Cellular Probes

Volumn 28, Issue 4, 2014, Pages 195-199

  Liguori, Rosario ^a,b   Labruna, Giuseppe ^c   Alfieri, Andreina ^a,d   Martone, Domenico ^a,d   Farinaro, Eduardo ^b   Contaldo, Franco ^b   Sacchetti, Lucia ^a,b   Pasanisi, Fabrizio ^b   Buono, Pasqualina ^a,d  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

FTO; MC4R; Metabolic syndrome; Morbid obesity; SIRT1; SNPs

Indexed keywords

CHOLESTEROL; SIRTUIN 1; FTO PROTEIN, HUMAN; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; PROTEIN; SIRT1 PROTEIN, HUMAN;

ADULT; ARTICLE; BASAL METABOLIC RATE; BLOOD ANALYSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DNA POLYMORPHISM; FAT FREE MASS; FAT MASS; FEMALE; FTO GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MC4R GENE; METABOLIC SYNDROME X; MORBID OBESITY; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; YOUNG ADULT; COMPLICATION; GENETICS; PATHOLOGY; STATISTICAL MODEL;

ADULT; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; ITALY; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; SIRTUIN 1;

EID: 84901259765     PISSN: 08908508     EISSN: 10961194     Source Type: Journal    
DOI: 10.1016/j.mcp.2014.03.004     Document Type: Article

References (39)

1. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88.
2. Marti A., Martinez-González M.A., Martinez J.A. Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc 2008, 67:1-8.
3. Ramachandrappa S., Farooqi I.S. Genetic approaches to understanding human obesity. JClin Invest 2011, 121:2080-2086.
4. Choquet H., Meyre D. Genetics of obesity: what have we learned?. Curr Genomics 2011, 12:169-179.
5. Chambers J.C., Elliott P., Zabaneh D., Zhang W., Li Y., Froguel P., et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 2008, 40:716-718.
6. Peng S., Zhu Y., Xu F., Ren X., Li X., Lai M. FTO gene polymorphisms and obesity risk: a metaanalysis. BMC Med 2011, 9:71.
7. Wang Y., Xu C., Liang Y., Vanhoutte P.M. SIRT1 in metabolic syndrome: where to target matters. Pharmacol Ther 2012, 136:305-318.
8. Bedogni G., Bellentani S., Miglioli L., Masutti F., Passalacqua M., Castiglione A., et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33.
9. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. American Heart Association, National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute.
10. Nagelkerke N.J.D. Anote on a general definition of the coefficient of determination. Biometrika 1991, 78:691-692.
11. Labruna G., Pasanisi F., Nardelli C., Caso R., Vitale D.F., Contaldo F., et al. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) 2011, 19(7):1492-1496.
12. Labruna G., Pasanisi F., Nardelli C., Tarantino G., Vitale D.F., Bracale R., et al. UCP1 -3826 AG+ GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity. JEndocrinol Invest 2009, 32(6):525-529.
13. Marchesini G., Melchionda N., Apolone G., Cuzzolaro M., Mannucci E., Corica F., et al. The metabolic syndrome in treatment-seeking obese persons. Metabolism 2004, 53:435-440. QUOVADIS Study Group.
14. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
15. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
16. van den Berg S.W., Dollé M.E., Imholz S., van der A.D.L., van't Slot R., Wijmenga C., et al. Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study. Int J Obes (Lond) 2009, 33:1143-1152.
17. Peeters A.V., Beckers S., Verrijken A., Mertens I., Roevens P., Peeters P.J., et al. Association of SIRT1 gene variation with visceral obesity. Hum Genet 2008, 124:431-436.
18. Weyrich P., Machicao F., Reinhardt J., Machann J., Schick F., Tschritter O., et al. SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention-the TULIP Study. BMC Med Genet 2008, 12:100-107.
19. Farooqi I.S. Monogenic human obesity. Front Horm Res 2008, 36:1-11.
20. Buono P., Pasanisi F., Nardelli C., Ieno L., Capone S., Liguori R., et al. Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy. Clin Chem 2005, 51:1358-1364.
21. Alfieri A., Pasanisi F., Salzano S., Esposito L., Martone D., Tafuri D., et al. Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy. Gene 2010, 457:35-41.
22. Tenesa A., Campbell H., Theodoratou E., Dunlop L., Cetnarskyj R., Farrington S.M., et al. Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population. Int J Obes (Lond) 2009, 33:284-288.
23. Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007, 3:e115.
24. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. Acommon variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
25. González-Sánchez J.L., Zabena C., Martínez-Larrad M.T., Martínez-Calatrava M.J., Pérez-Barba M., Serrano-Ríos M. Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain. Clin Endocrinol 2009, 70:390-393.
26. Li H., Kilpeläinen T.O., Liu C., Zhu J., Liu Y., Hu C., et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 2012, 55:981-995.
27. Lappalainen T., Kolehmainen M., Schwab U.S., Tolppanen A.M., Stančáková A., Lindström J., et al. Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism - The Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 2011, 21:691-698.
28. Jacobsson J.A., Risérus U., Axelsson T., Lannfelt L., Schiöth H.B., Fredriksson R. The common FTO variant rs9939609 is not associated with BMI in a longitudinal study on a cohort of Swedish men born 1920-1924. BMC Med Genet 2009, 10:131.
29. Hennig B.J., Fulford A.J., Sirugo G., Rayco-Solon P., Hattersley A.T., Frayling T.M., et al. FTO gene variation and measures of body mass in an African population. BMC Med Genet 2009, 10:21.
30. Ohashi J., Naka I., Kimura R., Natsuhara K., Yamauchi T., Furusawa T., et al. FTO polymorphisms in oceanic populations. JHum Genet 2007, 52:1031-1035.
31. Hardy R., Wills A.K., Wong A., Elks C.E., Wareham N.J., Loos R.J., et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet 2010, 19:545-552.
32. Tan J.T., Dorajoo R., Seielstad M., Sim X.L., Ong R.T., Chia K.S., et al. FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Diabetes 2008, 57:2851-2857.
33. Xi B., Shen Y., Zhang M., Liu X., Zhao X., Wu L., et al. The common rs9939609 variant of the fat mass and obesity-associated gene is associated with obesity risk in children and adolescents of Beijing, China. BMC Med Genet 2010, 11:107.
34. Rampersaud E., Mitchell B.D., Pollin T.I., Fu M., Shen H., O'Connell J.R., et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med 2008, 168:1791-1797.
35. Ruiz J.R., Labayen I., Ortega F.B., Legry V., Moreno L.A., Dallongeville J., et al. Attenuation of the effect of the FTO rs9939609 polymorphism on total and central body fat by physical activity in adolescents: the HELENA study. Arch Pediatr Adolesc Med 2010, 164:328-333.
36. Corella D., Carrasco P., Sorlí J.V., Coltell O., Ortega-Azorín C., Guillén M., et al. Education modulates the association of the FTO rs9939609 polymorphism with body mass index and obesity risk in the Mediterranean population. Nutr Metab Cardiovasc Dis 2012, 22:651-658.
37. Wang H., Dong S., Xu H., Qian J., Yang J. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol Biol Rep 2012, 39:5691-5698.
38. Freathy R.M., Timpson N.J., Lawlor D.A., Pouta A., Ben-Shlomo Y., Ruokonen A., et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 2008, 57:1419-1426.
39. Al-Attar S.A., Pollex R.L., Ban M.R., Young T.K., Bjerregaard P., Anand S.S., et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc Diabetol 2008, 7:5.